ALB and atrial fibrillation: Although metabolites in urine can be used as biomarkers of recent (∼24 h) exposure to AF [18], plasma AF B1-lysine adduct is the biomarker of choice for assessing exposure across months because of the long half-life of serum albumin in circulation [17].